# Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae

> **NCT04790565** · PHASE2,PHASE3 · COMPLETED · sponsor: **Rambam Health Care Campus** · enrollment: 15 (actual)

## Conditions studied

- Carbapenem-Resistant Enterobacteriaceae Infection

## Interventions

- **BIOLOGICAL:** FMT

## Key facts

- **NCT ID:** NCT04790565
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-10-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04790565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04790565, "Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04790565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*